Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.37 CAD | -1.24% | -0.47% | +2.08% |
May. 08 | Kits Eyecare Swings to Q1 Profit on Record Revenue | MT |
May. 08 | KITS Eyecare Brief: Q1 Revenue Increased 26% Year-Over-Year to a Record $34.8 million | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by -99% by 2026.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Other Specialty Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.08% | 149M | - | ||
-5.53% | 4.26B | B- | ||
-25.22% | 1.22B | C | ||
+17.90% | 756M | - | ||
-22.02% | 544M | - | ||
-23.30% | 374M | - | ||
+29.63% | 204M | - | - | |
-31.71% | 117M | - | - | |
-9.67% | 109M | - | ||
+0.33% | 92.65M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- KITS Stock
- Ratings Kits Eyecare Ltd.